Akums reported a robust 12.4% year-on-year revenue growth in Q4 FY25, reaching Rs.1,073 crore. The company closed FY25 with consolidated total income of Rs. 4,170 crore and an adjusted EBITDA margin of 12.3%, showing a 7-basis point improvement. Akums secured a significant EUR200 million contract for pharmaceutical products in regulated European markets, expanding its global […]